Cargando…
Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
OBJECTIVE: To establish the prevalence and associations of systemic antibiotic prescription for impetigo by early-career general practitioners (GPs) (GP registrars in their first 18 months in general practice). DESIGN: A cross-sectional analysis of data from the Registrar Clinical Encounters in Trai...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830714/ https://www.ncbi.nlm.nih.gov/pubmed/31662391 http://dx.doi.org/10.1136/bmjopen-2019-031527 |
_version_ | 1783465826357084160 |
---|---|
author | Heal, Clare Gorges, Hilary van Driel, Mieke L Tapley, Amanda Davis, Josh Davey, Andrew Holliday, L Ball, Jean Najib, Nashwa Spike, Neil FitzGerald, Kristen Magin, Parker |
author_facet | Heal, Clare Gorges, Hilary van Driel, Mieke L Tapley, Amanda Davis, Josh Davey, Andrew Holliday, L Ball, Jean Najib, Nashwa Spike, Neil FitzGerald, Kristen Magin, Parker |
author_sort | Heal, Clare |
collection | PubMed |
description | OBJECTIVE: To establish the prevalence and associations of systemic antibiotic prescription for impetigo by early-career general practitioners (GPs) (GP registrars in their first 18 months in general practice). DESIGN: A cross-sectional analysis of data from the Registrar Clinical Encounters in Training (ReCEnT) study. SETTING: ReCEnT is an ongoing multisite cohort study of Australian registrars’ in-consultation clinical practice across five Australian states. PARTICIPANTS: Registrars participating in ReCEnT from 2010 to 2017. OUTCOME MEASURES: Management of impetigo with systemic antibiotics. RESULTS: 1741 registrars (response rate 96%) provided data from 384 731 problems identified in 246 434 consultations. Impetigo, on first presentation or follow-up, was managed in 930 (0.38%, 95% CI 0.35 to 0.40) consultations and comprised 0.24% (95% CI 0.23 to 0.26) of problems. 683 patients presented with a new diagnosis of impetigo of which 38/683 (5.6%) were not prescribed antibiotics; 239/683 (35.0%) were prescribed solely topical antibiotics; 306/683 (44.8%) solely systemic antibiotics and 100/683 (14.6%) both systemic and topical antibiotics. The most common systemic antibiotic prescribed was cephalexin (53.5%). Variables independently associated with prescription of systemic antibiotics were an inner regional (compared with major city) location (OR 1.82, 95% CI 1.06 to 3.13; p=0.028), seeking in-consultation information or advice (OR 2.17, 95% CI 1.47 to 3.23; p<0.001) and ordering pathology (OR 2.13, 95% CI 1.37 to 3.33; p=0.01). CONCLUSIONS: Australian early-career GPs prescribe systemic antibiotics (the majority broad-spectrum) for a high proportion of initial impetigo presentations. Impetigo guidelines should clearly specify criteria for systemic antibiotic prescription and individual antibiotic choice. The role of non-antibiotic management and topical antiseptics needs to be explored further. |
format | Online Article Text |
id | pubmed-6830714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-68307142019-11-20 Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo Heal, Clare Gorges, Hilary van Driel, Mieke L Tapley, Amanda Davis, Josh Davey, Andrew Holliday, L Ball, Jean Najib, Nashwa Spike, Neil FitzGerald, Kristen Magin, Parker BMJ Open Infectious Diseases OBJECTIVE: To establish the prevalence and associations of systemic antibiotic prescription for impetigo by early-career general practitioners (GPs) (GP registrars in their first 18 months in general practice). DESIGN: A cross-sectional analysis of data from the Registrar Clinical Encounters in Training (ReCEnT) study. SETTING: ReCEnT is an ongoing multisite cohort study of Australian registrars’ in-consultation clinical practice across five Australian states. PARTICIPANTS: Registrars participating in ReCEnT from 2010 to 2017. OUTCOME MEASURES: Management of impetigo with systemic antibiotics. RESULTS: 1741 registrars (response rate 96%) provided data from 384 731 problems identified in 246 434 consultations. Impetigo, on first presentation or follow-up, was managed in 930 (0.38%, 95% CI 0.35 to 0.40) consultations and comprised 0.24% (95% CI 0.23 to 0.26) of problems. 683 patients presented with a new diagnosis of impetigo of which 38/683 (5.6%) were not prescribed antibiotics; 239/683 (35.0%) were prescribed solely topical antibiotics; 306/683 (44.8%) solely systemic antibiotics and 100/683 (14.6%) both systemic and topical antibiotics. The most common systemic antibiotic prescribed was cephalexin (53.5%). Variables independently associated with prescription of systemic antibiotics were an inner regional (compared with major city) location (OR 1.82, 95% CI 1.06 to 3.13; p=0.028), seeking in-consultation information or advice (OR 2.17, 95% CI 1.47 to 3.23; p<0.001) and ordering pathology (OR 2.13, 95% CI 1.37 to 3.33; p=0.01). CONCLUSIONS: Australian early-career GPs prescribe systemic antibiotics (the majority broad-spectrum) for a high proportion of initial impetigo presentations. Impetigo guidelines should clearly specify criteria for systemic antibiotic prescription and individual antibiotic choice. The role of non-antibiotic management and topical antiseptics needs to be explored further. BMJ Publishing Group 2019-10-28 /pmc/articles/PMC6830714/ /pubmed/31662391 http://dx.doi.org/10.1136/bmjopen-2019-031527 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Infectious Diseases Heal, Clare Gorges, Hilary van Driel, Mieke L Tapley, Amanda Davis, Josh Davey, Andrew Holliday, L Ball, Jean Najib, Nashwa Spike, Neil FitzGerald, Kristen Magin, Parker Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo |
title | Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo |
title_full | Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo |
title_fullStr | Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo |
title_full_unstemmed | Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo |
title_short | Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo |
title_sort | antibiotic stewardship in skin infections: a cross-sectional analysis of early-career gp’s management of impetigo |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830714/ https://www.ncbi.nlm.nih.gov/pubmed/31662391 http://dx.doi.org/10.1136/bmjopen-2019-031527 |
work_keys_str_mv | AT healclare antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT gorgeshilary antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT vandrielmiekel antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT tapleyamanda antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT davisjosh antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT daveyandrew antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT hollidayl antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT balljean antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT najibnashwa antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT spikeneil antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT fitzgeraldkristen antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo AT maginparker antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo |